To evaluate whether SEC62 and SOX2 expression exerts any influence on lymphatic metastasis of HNSCCs, we analyzed the expression levels of both genes in the primary tumor and the lymph node metastases from all 65 HNSCC patients using immunohistochemical staining. The gene discussed is SEC62; the disease is neoplasm.